https://scholars.lib.ntu.edu.tw/handle/123456789/501861
標題: | An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype | 作者: | MING-KAI CHUANG Chiu Y.-C. WEN-CHIEN CHOU HSIN-AN HOU Tseng M.-H. Kuo Y.-Y. Chen Y. Chuang E.Y. HWEI-FANG TIEN |
公開日期: | 2015 | 卷: | 6 | 期: | 36 | 起(迄)頁: | 39098-39110 | 來源出版物: | Oncotarget | 摘要: | Although clinical features, cytogenetics, and mutations are widely used to predict prognosis in patients with acute myeloid leukemia (AML), further refinement of risk stratification is necessary for optimal treatment, especially in cytogenetically normal (CN) patients. We sought to generate a simple gene expression signature as a predictor of clinical outcome through analyzing the mRNA arrays of 158 de novo CN AML patients. We compared the gene expression profiles of patients with poor response to induction chemotherapy with those who responded well. Forty-six genes expressed differentially between the two groups. Among them, expression of 11 genes was significantly associated with overall survival (OS) in univariate Cox regression analysis in 104 patients who received standard intensive chemotherapy. We integrated the z-transformed expression levels of these 11 genes to generate a risk scoring system. Higher risk scores were significantly associated with shorter OS (median 17.0 months vs. not reached, P < 0.001) in ours and another 3 validation cohorts. In addition, it was an independent unfavorable prognostic factor by multivariate analysis (HR 1.116, 95% CI 1.035~1.204, P = 0.004). In conclusion, we developed a simple mRNA expression signature for prognostication in CN-AML patients. This prognostic biomarker will help refine the treatment strategies for this group of patients. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/501861 | ISSN: | 1949-2553 | DOI: | 10.18632/oncotarget.5390 | SDG/關鍵字: | messenger RNA; messenger RNA; acute myeloblastic leukemia; adolescent; adult; AIF1L gene; Article; cancer chemotherapy; cancer prognosis; cohort analysis; comparative study; CXCR7 gene; DNTT gene; female; gene; gene expression profiling; gene function; genetic association; genetic identification; GPR56 gene; H1F0 gene; human; IFITM3 gene; induction chemotherapy; karyotype; KIAA0125 gene; major clinical study; male; MX1 gene; overall survival; risk assessment; scoring system; STAB1 gene; survival rate; TM4SF1 gene; TNS3 gene; treatment response; acute myeloid leukemia; biosynthesis; genetics; karyotyping; metabolism; middle aged; prognosis; survival analysis; Female; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; RNA, Messenger; Survival Analysis |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。